Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people.
Cell Rep Med
; 3(9): 100739, 2022 09 20.
Article
in En
| MEDLINE
| ID: mdl-36075216
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Limits:
Aged
/
Humans
Language:
En
Journal:
Cell Rep Med
Year:
2022
Type:
Article
Affiliation country:
United kingdom